Innovation

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

21 min.

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

11 min.

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

10 min.

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

9 min.

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

8 min.

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

10 min.

Renal Denervation — Trialist Perspectives

7 min.

What Will the Next Trial Designs Look Like for Renal Denervation?

22 min.

Renal Denervation — Clinician Perspectives

19 min.

Renal Denervation — Industry Perspectives

5 min.

TCT 832: Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

5 min.

Innovation in Interventional PE Therapies

9 min.

New technology update for CLI : Scaffolds

8 min.

Reflow Medical’s Temporary Spur DES System

3 min.

APTITUDE PLLA BRS (R3 Vascular)

4 min.

Hybrid Nano-Coating DES for BTK Disease

6 min.

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

4 min.

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound-Controlled, Multinational, Multispecialty Trial (CGuard OPTIMA)

5 min.

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

4 min.

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

10 min.